Singer Jesy Nelson recently shared an emotional update regarding the complications she is experiencing in her pregnancy with twin babies. Former Little Mix singer Jesy, who is having twins with partner Zion Foster, announced that she has been diagnosed with pre-twin-to-twin transfusion syndrome (pre-TTTS). The condition, which is present in pregnancies involving twins with a shared placenta, has serious risks involved and needs intense medical supervision. As Nelson embarks on this difficult journey, her story enlightens us about a rare but dangerous condition many expectant parents may not know much about.
Twin-to-twin transfusion syndrome is a rare but dangerous condition that arises in monochorionic twin pregnancies, in which identical twins share a single placenta. The placenta supplies the developing babies with oxygen, nutrients, and blood flow, but in TTTS, there is an imbalance of blood vessels that interconnect the twins, and thus the vital resources are not evenly distributed. One twin, or the donor twin, shares excess blood with the other, referred to as the recipient twin. This leads to one baby becoming malnourished and possibly anemic, and the other in danger of heart problems due to too much blood.
Nelson described her diagnosis in a heartfelt Instagram video, explaining that she is currently in the pre-stage of TTTS and undergoing frequent monitoring. "I am being scanned twice a week, and each time, things have gotten a little worse," she shared, expressing her fears and hopes for the health of her babies.
If left untreated, TTTS can have devastating consequences. Medical research indicates that:
TTTS usually advances in stages, beginning with minimal changes in fluid levels and worsening as one twin continues to get an unequal share of blood. In extreme cases, fetal laser surgery, referred to as the Solomon technique, can be employed to divide the blood vessels and balance the twins.
Identical twins may develop differently, and their own unique form of placental sharing can have a dramatic effect on pregnancy risk. Jesy Nelson's twins are considered monochorionic diamniotic (mono/di), which means they share a placenta but have two amniotic sacs. This is the type of pregnancy in about 70% of identical twin pregnancies and carries an increased risk of complications like TTTS, umbilical cord entanglement, and growth restriction.
Conversely, dichorionic diamniotic (di/di) twins both have a separate placenta and amniotic sac, which greatly diminishes the threat of TTTS. Twin pregnancy type is normally identified by early ultrasound, with physicians being able to track future complications from inception.
Twin pregnancies, even without the presence of TTTS, entail a variety of health risks to the mother as well as infants:
Over 60% of twin pregnancies end in premature delivery, with birth usually taking place before 37 weeks. Premature infants can have immature organs and need neonatal intensive care (NICU) assistance to assist with breathing, feeding, and infection fighting.
Pregnant women with multiples are at increased risk of having high blood pressure during pregnancy. This, if left untreated, can result in preeclampsia, a serious complication of pregnancy that can result in damage to organs, preterm labor, and in some cases, maternal or fetal death.
Pregnant women carrying multiples are twice as likely to experience anemia, a condition where the body does not produce enough healthy red blood cells. This can lead to fatigue, dizziness, and complications during delivery.
According to John Hopkins Medicine, multiple birth babies are twice as likely to have congenital abnormalities compared to single births. These can include heart defects, neural tube defects, and gastrointestinal issues.
When twins have to share a placenta, they are more likely to have polyhydramnios (excess amniotic fluid) or oligohydramnios (not enough amniotic fluid). Both result in distress to the babies during fetal development and can result in premature labor.
Twins are at increased risk of excessive postpartum hemorrhage because their uterus is larger and there are greater blood supply needs.
Jesy Nelson's openness about her challenging experience is raising awareness for TTTS, a condition that few individuals—let alone expectant mothers and fathers—might be aware of. Through her tearful video, Nelson stressed the significance of knowing about twin pregnancies aside from the thrill of having multiples. "We had no idea that this type of thing occurs when you're having twins. We just desperately want to make people aware of this because there are so many people who aren't aware."
Her case reminds us of the intricacies involved in twin pregnancy and the significance of early identification and medical management. For mothers carrying twins, frequent ultrasounds and vigilance can become a life-and-death issue for early detection and better outcomes of both babies.
Through constant medical attention and care, she and her partner Zion Foster remain positive and get ready for their babies to be born. In other parents whose situations are no different, the story of Nelson highlights awareness, medical progress, and emotional encouragement in handling complicated pregnancies.
The expecting parents of twin siblings are advised to discuss TTTS screening and possible interventions with their physicians to give their babies the best chance.
Credit: iStock
NHS England has announced the rollout of free home HPV testing kits, which could make cervical screening more accessible to nearly 4 million women who are not currently up to date with their screening.
The move is being described as a “game-changer”, as around a third of eligible women are not up to date with their cervical screening. The kits aim to provide a more “discreet and convenient option” for women who may not have attended screening previously.
“Offering millions of women an alternative test they can do from the comfort of their own homes will be a game-changer – making it easier than ever for them to get tested for HPV,” said Dr Sue Mann, National Clinical Director for Women’s Health at NHS England.
Importantly, the NHS stated that the home HPV testing is "not a replacement for cervical screening". Cervical screening appointments with a clinician remains the best way to help prevent cervical cancer.
The NHS is introducing HPV self-testing as an additional option for people who have not taken up previous invitations.
The initiative is also part of the NHS pledge to eliminate cervical cancer by 2040, by making it as easy as possible for people to get lifesaving HPV vaccination and increasing cervical screening attendance.
The self-testing kit contains a swab, similar to a long cotton bud, which is used to collect a sample from the vagina. The sample is then posted back to the NHS for free, where it is checked for high-risk HPV.
If high-risk HPV is found, individuals will be invited to book a follow-up cervical screening appointment at their GP surgery or sexual health clinic. A nurse or doctor will then take a small sample from the cervix to check for cell changes.
HPV self-testing is an invitation-only offer and is being rolled out in phases across England as part of the NHS Cervical Screening Programme.
The rollout starts with people aged 30 to 65 who have not attended cervical screening following previous invitations.
Women aged 24 to 64 are invited for cervical screening by the NHS every five years, or more frequently if HPV is detected.
Women who are eligible will start receiving invitations via the NHS App, text message, email or letter. Once invited, they will be able to order a free kit through the NHS App or their NHS online account.
“There are lots of reasons that may stop women from getting their cervical screening – embarrassment, lack of time, or worries about discomfort – and these kits provide a discreet and convenient option we hope will encourage more women to take up the life-saving test. So, if you’re invited to take part, please order a test – it’s a simple swab you can do at home in minutes,” she added.
Cervical screening helps prevent cervical cancer by checking for high-risk types of HPV. HPV is a common virus that can cause changes to cells in the cervix. These changes can usually be treated before cancer develops.
The NHS noted that it is still important to attend cervical screening appointments even if you have been vaccinated against HPV.
The HPV vaccine does not protect from all types of HPV, so there is still a small chance of developing cervical cancer.
People who routinely attend cervical screening with a clinician at their GP practice or sexual health clinic should continue to book their appointments as normal.
Anyone who has been invited for cervical screening can still book an appointment at any time, even if the invitation was sent months or years ago.
Credit: FDA/iStock
The US FDA has announced a nationwide recall of Vitruvias Therapeutics' Thyroid Tablets USP 30 mg over potential super-potency, which may cause hyperthyroidism (overactive thyroid).
In a recall notice issued on August 24, the company said the affected thyroid tablets, with lot number 504950, were potentially superpotent.
“Consumption of superpotent Thyroid tablets can cause hyperthyroidism (overactive thyroid) including, but not limited to, weight loss, heat intolerance, fatigue, nervousness, muscle weakness, hypertension, chest pain, rapid heart rate, or heart rhythm disturbances,” the company said.
The recalled product is:
The lot was distributed nationwide in the US to Vitruvias Therapeutics’ direct accounts from January 31, 2025, to September 30, 2025.
A total of 3,655 units were released, of which 1,955 were sold during the distribution period.
The company noted that patient populations at greater risk from superpotent thyroid tablets include
Excess levels of thyroid hormones in elderly people have been associated with adverse outcomes, particularly affecting cardiac health.
However, Vitruvias Therapeutics said it has not received any reports of adverse events known to be related to this recall.
The company noted that it is proactively notifying wholesalers by email and phone to discontinue distribution of the recalled product and is arranging for the destruction of all recalled products.
Patients currently taking Thyroid, USP from Lot 504950 should not discontinue use without contacting their healthcare provider for further guidance and/or a replacement prescription.
The thyroid is a small gland located in the neck, but it plays an important role in the body's activities. It secretes hormones that control metabolism, or the body's ability to convert food into energy.
Thyroid hormones also regulate several other body functions, including heart rate and body temperature.
When the thyroid gland becomes underactive, a condition called hypothyroidism occurs. It causes bodily functions to slow down. Metabolism may also be reduced, leading to changes in a person's well-being.
Speaking to HealthandMe, Dr Shruti Kotangale, Consultant Gynaecologist, Obstetrician and Infertility Expert at AIMS Hospital, Dombivli, explained that conditions such as hypothyroidism and hyperthyroidism are commonly seen in women.
Hypothyroidism occurs when the thyroid gland is underactive. Symptoms can include tiredness, weight gain, dry skin, hair fall, constipation, feeling cold, a slow heartbeat and low mood or depression.
Hyperthyroidism occurs when the thyroid gland becomes overactive. Women may experience weight loss, a fast heartbeat, sweating, anxiety, tremors, irritability, frequent bowel movements, and difficulty sleeping.
Women must seek medical attention and manage these symptoms without delay.
Although weight fluctuations are the most common thyroid abnormality, they are typically accompanied by a group of symptoms, including:
Obtaining a proper diagnosis requires two key steps:
Physical examination: This helps determine whether there is swelling or a nodule in the neck.
Blood tests: These may determine levels of:
Credit: AI
A UK skin cancer survivor is urging the government to remove VAT from sunscreen, arguing that products used to protect against skin cancer should not be treated as luxury cosmetics.
Jessica Zbinden-Webster, who was diagnosed with skin cancer at just 26, has renewed her campaign to scrap the 20% VAT charged on sunscreen. She said that sunscreen should be considered a health essential rather than a cosmetic product.
Zbinden-Webster's campaign comes as skin cancer remains a growing public health concern in the UK.
UV radiation can damage the DNA inside skin cells. Repeated or excessive exposure can cause mutations that increase the risk of skin cancer.
Melanoma, the most serious form of skin cancer, can develop when pigment-producing cells become cancerous. Non-melanoma skin cancers, including basal cell carcinoma and squamous cell carcinoma, are also strongly influenced by UV exposure.
Cancer Research UK says up to nine in 10 melanoma cases could be prevented by staying safe in the sun and avoiding sunbeds. It recommends using sunscreen alongside shade and protective clothing.
The campaign argues that the way sunscreen is taxed sends the wrong message about its role in disease prevention.
Experts agree that removing VAT from SPF 30+ sunscreen could potentially prevent thousands of melanoma cases and save the NHS more than £128 million a year in treatment costs.
Experts also stress that sunscreen should not be viewed as a license to spend long hours in the sun. Cancer Research UK recommends using SPF 30 or higher with good UVA protection, applying it generously and reapplying regularly. It also advises seeking shade, particularly around the middle of the day, and covering exposed skin with clothing and a hat.
The organisation also points out that UV radiation can damage skin even when the weather feels cool or cloudy, because temperature does not determine UV intensity.
Also read: Does Sunscreen Really Raise Skin Cancer Risk? What The 470,000-Person Study Found
Zbinden-Webster's own experience has made the issue personal. After her cancer diagnosis, she underwent surgery that removed part of her lower eyelid, followed by a skin graft and further procedures. She has since made daily sunscreen use part of her routine and argues that cost should not become a barrier to prevention.
The campaign is now calling on the UK government to reconsider the VAT classification of sunscreen, particularly products with SPF 30 or higher. She said that sunscreen is only one part of sun protection, but making preventive products more affordable could potentially encourage more people to use them consistently.
Sunscreen can help reduce UV exposure, but it should not be the only line of defence. Cancer Research UK recommends combining sunscreen with shade and protective clothing.
© 2024 Bennett, Coleman & Company Limited